Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed.
The impact ofAlzheimer's & dementia (Amsterdam, Netherlands)
Article
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Rafael Lara NohmiLaboratory of Molecular and Cellular Biology (LIM 15) Department of Neurology Faculdade de Medicina FMUSP Universidade de São Paulo São Paulo São Paulo Brazil.ORCID https://orcid.org/0009-0000-8617-966X
Mozania Reis de MatosLaboratory of Molecular and Cellular Biology (LIM 15) Department of Neurology Faculdade de Medicina FMUSP Universidade de São Paulo São Paulo São Paulo Brazil.ORCID https://orcid.org/0000-0002-4434-9170
Sueli Mieko Oba-ShinjoLaboratory of Molecular and Cellular Biology (LIM 15) Department of Neurology Faculdade de Medicina FMUSP Universidade de São Paulo São Paulo São Paulo Brazil.ORCID https://orcid.org/0000-0002-1650-5973
Paula Rodrigues SolaLaboratory of Molecular and Cellular Biology (LIM 15) Department of Neurology Faculdade de Medicina FMUSP Universidade de São Paulo São Paulo São Paulo Brazil.ORCID https://orcid.org/0000-0001-6452-1436
Miyuki UnoCenter for Translational Research in Oncology Instituto do Câncer do Estado de São Paulo (ICESP) Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo Sao Paulo São Paulo Brazil.ORCID https://orcid.org/0000-0003-2589-6432
Marisa PassarelliLaboratório de Lípides (LIM 10) Hospital das Clínicas HCFMUSP Faculdade de Medicina Universidade de São Paulo São Paulo São Paulo Brazil.ORCID https://orcid.org/0000-0002-9249-4698
Michal Schnaider BeeriThe Herbert and Jacqueline Krieger Klein Professor of Neurology Robert Wood Johnson Medical School New Brunswick New Jersey USA.ORCID https://orcid.org/0000-0002-4254-9742
Sharon Sanz SimonDepartment of Psychiatry Rutgers New Jersey Medical School The Krieger Klein Alzheimer´s Research Center Newark New Jersey USA.ORCID https://orcid.org/0000-0003-2603-6215
Maria Lucia Correa-GiannellaLaboratório de Carboidratos e Radioimunoensaio (LIM-18) Hospital das Clínicas HCFMUSP Faculdade de Medicina Universidade de São Paulo São Paulo Brazil.ORCID https://orcid.org/0000-0003-3655-4446
Suely Kazue Nagahashi MarieLaboratory of Molecular and Cellular Biology (LIM 15) Department of Neurology Faculdade de Medicina FMUSP Universidade de São Paulo São Paulo São Paulo Brazil.ORCID https://orcid.org/0000-0003-4419-7928
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
introductionType 2 diabetes (T2D) is associated with cognitive decline, but the role of
methodsWe analyzed 883 Brazilian adults with T2D (median age 68 years) from primary care, excluding those with dementia. Cognitive function was assessed using Mini-Mental State Examination (MMSE), and
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.